NLC-Based Rifampicin Delivery System: Development and Characterization for Improved Drug Performance Against <i>Staphylococcus aureus</i>

NLC-Based Rifampicin Delivery System: Development and Characterization for Improved Drug Performance Against <i>Staphylococcus aureus</i>

<b>Background/Objectives</b>: Rifampicin is a typical antibiotic used for the treatment of <i>Staphylococcus aureus</i> (<i>S. aureus</i>) infections; however, its clinical utility is limited by poor aqueous solubility, chemical instability, and increasing bacteri...

Full description

Saved in:
Bibliographic Details
Main Authors: Javiera Carrasco-Rojas, Felipe I. Sandoval, Christina M. A. P. Schuh, Carlos F. Lagos, Javier O. Morales, Francisco Arriagada, Andrea C. Ortiz
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Pharmaceutics
Subjects:
nanostructured lipid carrier
antibiotic
rifampicin
drug release
<i>Staphylococcus aureus</i>
HepG2 cell
Online Access:https://www.mdpi.com/1999-4923/17/6/799
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items